Interleukin-18 in Adult-onset Still's Disease: Treatment Target or Disease Activity Indicator?
Author:
Affiliation:
1. Division of Rheumatology and Clinical Immunology, Department of Medicine, Jichi Medical University, Japan
Publisher
Japanese Society of Internal Medicine
Subject
General Medicine,Internal Medicine
Link
http://www.jstage.jst.go.jp/article/internalmedicine/51/4/51_4_449/_pdf
Reference5 articles.
1. Tocilizumab Improved both Clinical and Laboratory Manifestations Except for Interleukin-18 in a Case of Multiple Drug-Resistant Adult-Onset Still's Disease
2. Glucocorticoid and cyclosporine refractory adult onset Still’s disease successfully treated with tocilizumab
3. Rapid responses to anakinra in patients with refractory adult-onset Still's disease
4. Comment on: Usefulness of anti-cyclic citrullinated peptide antibody and rheumatoid factor to detect rheumatoid arthritis in patients with systemic sclerosis
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Systematic review on the use of biologics in adult-onset still's disease;Seminars in Arthritis and Rheumatism;2023-02
2. Biologics for the treatment of adult-onset still’s disease;Expert Opinion on Biological Therapy;2019-08-14
3. CHARACTERISTICS OF ADULT-ONSET STILL’S DISEASE IN THE 21ST CENTURY;Rheumatology Science and Practice;2018-09-08
4. Treatment of adult-onset Still’s disease: a review;Therapeutics and Clinical Risk Management;2014-12
5. Interleukin 1 inhibition with anakinra in adult-onset Still disease: a meta-analysis of its efficacy and safety;Drug Design, Development and Therapy;2014-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3